Abstract
Key Points
• Bronchiectasis is a disease with an increasing prevalence and substantial clinical and economic burden
• Once regarded as a neglected disease, bronchiectasis has experienced a renaissance in recent years with an increase in clinical research
• International guidelines now provide a framework for high-quality care and are increasingly informed by randomized clinical trials of high quality.
• Major developments in the past 10 years include international registries, clinical trials, guidelines, and translational research
• Bronchiectasis is a disease with an increasing prevalence and substantial clinical and economic burden
• Once regarded as a neglected disease, bronchiectasis has experienced a renaissance in recent years with an increase in clinical research
• International guidelines now provide a framework for high-quality care and are increasingly informed by randomized clinical trials of high quality.
• Major developments in the past 10 years include international registries, clinical trials, guidelines, and translational research
| Original language | English |
|---|---|
| Pages (from-to) | 1-6 |
| Number of pages | 6 |
| Journal | Clinics in Chest Medicine |
| Volume | 43 |
| Issue number | 1 |
| Early online date | 27 Feb 2022 |
| DOIs | |
| Publication status | Published - Mar 2022 |
Keywords
- Bronchiectasis
- Clinical trials
- Epidemiology
- Guidelines
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
